Perrigo Company PLC
http://www.perrigo.com/
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Perrigo Company PLC
Perrigo Rx Divestment Remains ‘On Track’
Perrigo says its deal to divest its Rx business remains “on track,” with the company shunting the prescription unit into “discontinued operations” in the first quarter as it trains its focus on the firm’s future growth engine of consumer self-care.
Perrigo’s Latest Brand Buzz: Making, Marketing Burt’s Bees Baby Formula And Supplements
Perrigo’s brand play extends to marketing Burt’s Bees organic baby formulas and “nature-based” supplements for infants and children. Burt’s Bees announcement offsets Q1 dips in domestic and international consumer health sales.
Salonpas Spreads Into OTC Diclofenac Arthritis Gel
Hisamitsu America launches Salonpas Arthritis Pain Relief Gel with same active ingredient, diclofenac sodium 1% gel, that became available OTC for the first time in the US in 2020 with GSK’s Voltaren Arthritis Pain formulation.
Perrigo Reaches $1.5bn Deal With Altaris For Rx Business
Perrigo has finally found the right deal to secure the long-awaited divestment of its prescription business, reaching an agreement worth just over $1.5bn with private equity firm Altaris Capital Partners.
Company Information
- Industry
- Biotechnology
- Pharmaceuticals
-
Pharmaceuticals
- Generic Drugs
- Nutraceuticals
- OTC, Consumer
-
Biotechnology
-
Drug Discovery Tools
-
Molecular Diversity
- Natural Products
-
Molecular Diversity
-
Drug Discovery Tools
- Other Names / Subsidiaries
-
- Agis Industries
- Chemagis
- Clay-Park Labs
- Cobrek Pharmaceuticals
- Elan Corporation
- JB Laboratories
- Onclave Therapeutics Limited
- Omega Pharma Invest N.V.
- Paddock Laboratories
- Omega Pharma Invest N.V.
- Ranir Global Holdings LLC
- Rosemont Pharmaceuticals Ltd.
- Unico Holdings Inc.
- Velcera, Inc.
- Geiss, Destin & Dunn, Inc.
- High Ridge Brands